NEW YORK, May 29, 2024 /PRNewswire/ -- Sarepta Therapeutics Inc. (NASD: SRPT) will replace Shockwave Medical Inc. (NASD: SWAV) in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson (NYSE: JNJ) is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Com ...

NEW YORK, May 8, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.  Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:  Shockwave Medical has agreed to merge with Joh ...

Shockwave Medical, Inc. (SWAV) reported first-quarter 2024 earnings per share (EPS) of $1.44, which beat the Zacks Consensus Estimate of $1.04 by 38.46%. The company reported an EPS of $1.03 in the year-ago quarter.Revenue DetailsRevenues totaled $218.8 million, indicating an uptick of 36% from the prior-year period’s level. The top line also beat the Zacks Consensus Estimate by 5.66%. The growth was primarily driven by an increase in the purchase volume of products, both in the United States and abroad.Bus ...

For the quarter ended March 2024, Shockwave Medical (SWAV) reported revenue of $218.81 million, up 35.8% over the same period last year. EPS came in at $1.44, compared to $1.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $207.09 million, representing a surprise of +5.66%. The company delivered an EPS surprise of +38.46%, with the consensus EPS estimate being $1.04.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wal ...

Shockwave Medical (SWAV) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 38.46%. A quarter ago, it was expected that this medical device compnay would post earnings of $0.92 per share when it actually produced earnings of $1.16, delivering a surprise of 26.09%.Over the last four quart ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ___________________________________________________ FORM 10-Q ___________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to ___________ Commission File Number: 001-38 ...

EXHIBIT 99.1 Shockwave Medical Reports First Quarter 2024 Financial Results SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended March 31, 2024. "The solid growth in the first quarter across geographies and products is a testament to the continued demand for our innovative solution ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Shockwave Medical (SWAV) reports results for the quarter ended March 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the s ...

Shockwave Medical (SWAV) closed at $328.99 in the latest trading session, marking a +0.04% move from the prior day. This move outpaced the S&P 500's daily loss of 0.46%. At the same time, the Dow lost 0.98%, and the tech-heavy Nasdaq lost 0.64%.The the stock of medical device compnay has risen by 1.94% in the past month, leading the Medical sector's loss of 4.9% and the S&P 500's loss of 3.04%.Market participants will be closely following the financial results of Shockwave Medical in its upcoming release. O ...

Shockwave Medical (SWAV) closed the latest trading day at $329, indicating a +0.45% change from the previous session's end. This change outpaced the S&P 500's 0.88% loss on the day. Meanwhile, the Dow gained 0.56%, and the Nasdaq, a tech-heavy index, lost 2.05%.Shares of the medical device compnay witnessed a gain of 14.81% over the previous month, beating the performance of the Medical sector with its loss of 6.4% and the S&P 500's loss of 2.57%.Investors will be eagerly watching for the performance of Sho ...